|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Irinotecan synergistically enhances the antiproliferative and proapoptotic effects of axitinib in vitro and improves its anticancer activity in vivo 显示文摘 | Canu B Fioravanti A Orlandi P | 2011 | Neoplasia2011，13，21： | 1 |
| 2 | Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae 显示文摘 | Canu A Malbruny B Coquemont M | 2002 | Antimicrob Agents Chemother2002，46，1： | 1 |
| 3 | Kinetic experiments and modeling of a three phase catalytic hydrogenation reaction in supercritical carbon dioxide 显示文摘 | Devetta L Giovanzana A Canu P Bertucco A Minder B J | 1999 | Catalysis Today1999，48，14： | 1 |
| 4 | Diversity of ribosomal mutations conferring resistance to maerolides, elindamyein, streptogramin and telithromycin in Streptococcus pneumoniae显示文摘 | Canu A Malhruny B Coquemont M | 2002 | Antimierob Agents Chemother2002，46，1： | 1 |
| 5 | Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae 显示文摘 | Canu A Malbruny B Coquemont M | 2002 | Antimicrob Agents Chemother2002，46，： | 1 |
| 6 | Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae显示文摘 | Canu A Malbruny B Coquemont M | 2002 | Antimicrob Agents Chemother2002，46，1： | 1 |
| 7 | Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin , streptogramin , and telithromycin in Streptococcus pneumoniae 显示文摘 | CANU A MALBRUNY B COQUEBMONT M | 2002 | Antimicrob Agents Chemother2002，46，1： | 1 |
| 8 | Denaturing high-performance liquid chromatography detection of ribosomal mutations conferring macrolide resistance in Gram-positive cocci显示文摘 | Canu A Abbas A Malbruny B | 2004 | Antimicrob Agents Chemother2004，48，1： | 1 |
| 9 | Irinotecan synergistically enhances the antiproliferative and proapoptotic effects of axitinib in vitro and improves its anticancer activity in vivo显示文摘 | Canu B Fioravanti A Orlandi P | | 0，，： | 1 |
| 10 | Denaturing high-performance liquid chromatography detection of ribosomal mutations conferring macrolide resistance in gram-positive cocci显示文摘 | Canu A Abbas A Malbruny B | 2004 | Antimicrob Agents Chemother2004，48，1： | 1 |
| 11 | Metronomic 5-fluorouracil, oxaliplatin and irinotecan in coloreetal cancer 显示文摘 | FIORAVANTI A CANU B ALI G | 2009 | Eur J Pharmacol2009，619，13： | 1 |
| 12 | Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae 显示文摘 | Canu A Malbruny B Coquemont M | 2002 | Antimicrob Agents Chemother2002，46，1： | 1 |
| 13 | White matter isaltered with parental family history of Alzheimer’s disease显示文摘 | Bendlin B B Ries M L Canu E | 2010 | Alzheimers Dement2010，6，5： | 1 |
| 14 | Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae显示文摘 | Canu A Malbruny B Cocluemont M | 2002 | Antimicrob Agents Chemother2002，46，1： | 1 |
| 15 | Mapping local hippocampal changes in Alzheimer's disease and normal ageing with MRI at 3 Tesla 显示文摘 | FRISONI G B GANZOLA R CANU E | 2008 | Brain2008，131，： | 1 |
| 16 | Kinetic experiments and modeling of a three-phase catalytic hydrogenation reaction in supercritical CO2显示文摘 | DEVETTA L GIOVANZANA A CANU P BERTUCCO A MINDER B J | 1999 | Catal Today1999，48，14： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员